News
Latest News and Press Releases
Transfer of All Axcelead Shares to Whiz Partners DDG Fund Completed
April 1, 2019 – Whiz Partners Inc. (hereinafter, “Whiz”), headquartered in Minato Ward, Tokyo, announced that it...
Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement
Fujisawa, Japan and Dublin, Ireland, October 4, 2018 – Axcelead Drug Discovery Partners, Inc.(hereinafter referred to as...
Announcement on starting preparation to become a company independent from Takeda
We are pleased to announce that Axcelead Drug Discovery Partners Inc. (“Axcelead”) preparation to become a company...
Announcement of Start of Business Partnership between Axcelead and LAP&P for Modeling and Simulation of Drug Discovery
We are pleased to announce that Axcelead Drug Discovery Partners, Inc. (Yoshinori Ikeura, President; Headquarters: Fujisawa-shi, Kanagawa,...